HSBC Holdings’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,355
Closed -$179K 3095
2025
Q3
$179K Buy
+12,355
New +$162K ﹤0.01% 2517
2024
Q3
Sell
-10,515
Closed -$140K 3102
2024
Q2
$140K Sell
10,515
-12,310
-54% -$169K ﹤0.01% 2660
2024
Q1
$331K Buy
22,825
+9,694
+74% +$134K ﹤0.01% 2377
2023
Q4
$179K Buy
+13,131
New +$154K ﹤0.01% 2496
2023
Q1
Sell
-19,367
Closed -$385K 2938
2022
Q4
$385K Sell
19,367
-5,117
-21% -$90.3K ﹤0.01% 2403
2022
Q3
$477K Buy
+24,484
New +$551K ﹤0.01% 2192

Other funds holding OFIX

HSBC Holdings's OFIX Position: Q4 2025 in Review

HSBC Holdings sold out of Orthofix Medical (OFIX) in Q4 2025, closing a stake of 12,355 shares — an estimated $179K sold.

HSBC Holdings first reported a position in OFIX in Q3 2022 and held it in 6 quarters. The position peaked at $477K in Q3 2022. 143 funds tracked by Wall St. Rank hold OFIX as of Q4 2025.

  • HSBC Holdings reported no remaining Orthofix Medical position as of Q4 2025 after selling out during the quarter.
  • HSBC Holdings sold 12,355 Orthofix Medical shares in Q4 2025, an estimated $179K.
  • HSBC Holdings first reported a position in Orthofix Medical in Q3 2022 and held it in 6 quarters.
  • HSBC Holdings's Orthofix Medical position peaked at $477K in Q3 2022.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2025.

Based on HSBC Holdings's 13F filing for Q4 2025, filed 6 Mar 2026.